|
Match
|
Document |
Document Title |
|
|
7316816 |
Temperature and pH sensitive copolymers
The invention is directed to a copolymer comprising at least three types of monomeric units, said three types of monomeric units comprising:
a temperature-sensitive unit, a hydrophilic unit,...
|
|
|
7316818 |
Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
This invention comprises pharmaceutical compositions for administering a polycyclic, aromatic, antioxidant or anti-inflammatory compound to an animal. Particularly provided are proliposomal...
|
|
|
7314641 |
High-bioavailability particle coated with fungicide and polymer
The present invention discloses a high-bioavailability particle coated with fungicide and polymer, which mainly comprises: (a) a coating layer including fungicide, a polymer, an acidic substance,...
|
|
|
7314640 |
Formulation and process for drug loaded cores
The present invention relates to a controlled release pellet of metoprolol and its pharmaceutically acceptable salts that uses a water soluble or a water swellable inert starting seed or core.
|
|
|
7314639 |
Process for the production of crystals of a benzoic acid derivative
A method for preparing a crystal of 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)ca
rbamoyl]benzoic acid having a single endothermic peak approximately at 233° C. in differential...
|
|
|
7311900 |
Gel/air freshener system
A powder mixture for mixing with water to form a gel for a gel/air freshener system includes a fragrance, amorphous fumed silica, a super-absorbent polymer and a surfactant. The mixture can also...
|
|
|
7311925 |
Methods and compositions for blocking microbial adherence to eukaryotic cells
A method of blocking microbial adherence to a eukaryotic cell surface in a mammal by applying a pharmacologically acceptable composition containing at least one compound selected from the group...
|
|
|
7311926 |
Biocomposite materials and methods for making the same
A particle (and a composition that includes a plurality of the particles) that includes at least one polypeptide molecule and at least one polymer covalently bound to the polypeptide molecule so as...
|
|
|
7311731 |
Prevention of myocardial infarction induced ventricular expansion and remodeling
A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium...
|
|
|
7309500 |
Microparticles
A method of forming particles, comprises accelerating a first stream comprising a first liquid, applying a charging voltage of at most 1.5 kV to the first stream, and vibrating the first stream, to...
|
|
|
7306814 |
Method of growing crystals
A composition is provided comprising a substance of interest encapsulated by a continuous layer of a plurality of salt crystals which layer is impermeable to the substance of interest. Also...
|
|
|
7306809 |
Optically activated particles for use in cosmetic compositions
Optically activated particles for use in cosmetic and pharmaceutical compositions are disclosed. The optically activated particles include a solid substrate having a fluorescent compound fixed...
|
|
|
7303764 |
2-methyl-thieno-benzodiazepine formulation
The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel...
|
|
|
7303756 |
Multiphase system
The invention relates to a preparation comprising a carrier phase and at least one further phase which cannot be mixed with the carrier phase or only partially mixed therewith, wherein the change...
|
|
|
7303767 |
Personal care compositions comprising coated/treated metal silicate absorbent particles
Coated particles of metal (such as calcium) silicate that exhibit excellent odor neutralization and sebum absorption properties when present within certain cosmetic and/or personal care...
|
|
|
7303755 |
Pharmaceutical compositions with antibiotic activity
The use of certain salts and aminoacids as stabilizer of the antibiotic Fosfomycin Tromethamol and pharmaceutical compositions containing them, is described.
|
|
|
7303765 |
Ultrafine-L-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
L-carnitine which has a particle size such that it substantially passes through a 100 USBS mesh sieve exhibits an increased bioavailability, a decreased hygroscopicity, and may be conveniently...
|
|
|
7303766 |
Coated/treated metal silicate absorbent particles
Coated particles of metal (such as calcium) silicate that exhibit excellent odor neutralization and sebum absorption properties when present within certain cosmetic and/or personal care...
|
|
|
7300670 |
Oral suspension formulation
An aqueous pharmaceutical suspension for oral administration of a drug, which suspension maintains its content uniformity for prolonged period.
|
|
|
7300672 |
Titanium-group metal containing high-performance water, and its producing method and apparatus
Produce titanium-group metal micro-dispersion water that contains ion vapor of titanium-group metal in micro-dispersed state and that can be used as a material for health products, medical...
|
|
|
7294349 |
Wrinkle cream
An emulsion comprising: water; hydrophilic particles; and hydrophobic particles; wherein the hydrophilic and hydrophobic particles form shells encapsulating a gas that are suspended in the water,...
|
|
|
7294350 |
Healing powder and method of use thereof
A wound healing powder, comprising a sugar selected from the group consisting of one or more pharmaceutically acceptable monosaccharides and disaccharides, in an amount of at least 25% by weight of...
|
|
|
7294344 |
Sustained-release preparation for AII antagonist, production and use thereof
The present invention is to provide a sustained-release preparation which comprises a compound having angiotensin II antagonistic activity, its pro-drug or their salt, and a biodegradable polymer,...
|
|
|
7291348 |
Compositions and methods for biodegradable microspheres as carriers of bioactive substances
A cost-effective, scalable technique for producing microspheres loaded with biologically active solid proteins is provided. The microspheres degrade over time and release biologically active VEGF,...
|
|
|
7288268 |
Formulation for the treatment of obesity
The present invention refers to a formulation for a slimming treatment comprising in certain quantities: hypothalamus powder, hypophysis powder, thyroid powder, suprarenal cortex powder and...
|
|
|
7288267 |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
Bioadhesive nanoparticulate compositions, comprising active agent particles and one or more cationic surface stabilizers, are described. The cationic surface stabilizers prevent aggregation of the...
|
|
|
7285576 |
Absorbent polymer compositions, medical articles, and methods
An absorbent polymer composition, which can be in the form of a foam, that includes a polymeric material, absorbent particles and thermally expandable (or expanded) microspheres.
|
|
|
7285284 |
Cosmetic composition, method of use and method of making
A cosmetic composition for use as scrubbing agent or a mask uses vitamin C particles or crystals in an oil base, whereby the particles are insoluble in the oil so that they remain as suspended...
|
|
|
7285290 |
Hydrophilized powder and a composition comprising the same
The present invention is hydrophilized powder, wherein the powder is surface treated with polyether-modified silicone having a hydrolyzable silyl group according to the formula (1),
...
|
|
|
7285298 |
Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment
The use of a dihydrochalcone-rich polyphenolic fraction in the cosmetic treatment of mammals in order to limit the weight, to improve the aesthetic appearance of the body, and to treat certain...
|
|
|
7282220 |
Genipin-crosslinked gelatin microspheres as drug carrier
A pharmaceutical microsphere comprises a bioactive agent and a biological carrier that encapsulates the bioactive agent, wherein the biological carrier is crosslinked with a crosslinking agent.
|
|
|
7282219 |
Powdery preparation for transmucosal administration containing a polymeric form of drug and exhibiting improved storage stability
A powdery preparation for transmucosal administration comprising a medicine of high molecular weight, a cationic polymer and, as needed, a viscous polymer, further comprising an effective amount of...
|
|
|
7282221 |
Antiviral product, use and formulation thereof
An antiviral product is comprised of at least three dosages forms, each of which has a different release profile, with the C max for the antiviral product being reached in less than about twelve...
|
|
|
7282215 |
Supports for photosensitizer formulations
The invention is generally related to the field of formulating medicaments in association with a solid support. Such formulations comprising photosensitizers, and their use in photodynamic therapy,...
|
|
|
7279181 |
Method for preparation of particles from solution-in-supercritical fluid or compressed gas emulsions
The present invention provides a method of producing particles from solution-in-supercritical fluid or compressed gas emulsions. In accordance with the method of the invention, a solution that...
|
|
|
7279180 |
Stable emulsions and dry powders of mixtures of fat-soluble vitamins, their preparation and use
The present invention relates to stable emulsions and dry powders of mixtures of fat-soluble vitamins, and to processes for their preparation and to their use.
|
|
|
7278843 |
Methods for fine powder formation
Improved methods for forming fine particles of a material have been developed, wherein the method steps include dissolving the material in a solvent to form a dilute solution, immobilizing the...
|
|
|
7279182 |
Formulation for spray-drying large porous particles
Particles having a tap density less than about 0.4 g/cm3 are formed by spray drying from a colloidal solution including a carboxylic acid or salt thereof, a phospholipid, a divalent salt and a...
|
|
|
7276249 |
Nanoparticulate fibrate formulations
The present invention is directed to fibrate compositions having improved pharmacokinetic profiles and reduced fed/fasted variability. The fibrate particles of the composition have an effective...
|
|
|
7276190 |
Process for the production of micro and/or nano particles
A process and an apparatus are proposed to perform the supercritical assisted atomization of nano and/or micro metric powders. It is possible to use liquid solvent at process conditions in which...
|
|
|
7276254 |
Emulsion/aggregation polymeric microspheres for biomedical applications and methods of making same
A method of forming polymeric microspheres for biomedical applications includes forming polymeric microspheres by an emulsion/aggregation process from a precursor monomer species, and treating the...
|
|
|
7276251 |
Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
A sustained-release drug composition consisting essentially of microparticles of hyaluronic acid having a high molecular weight or an inorganic salt thereof and a protein or peptide drug encased in...
|
|
|
7276253 |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
The invention relates to a stable medicament for oral administration which comprises
(a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole,...
|
|
|
7273623 |
Process for preparing tannate tablet, capsule or other solid dosage forms
An active pharmaceutical ingredient is combined with tannic acid to form a tannate salt complex of the active ingredient. The active ingredient tannate salt complex without isolation or...
|
|
|
7273521 |
Method of producing granulated calcium carbonate/calcium phosphate composite materials with very high calcium to phosphate mole ratios
A new and useful method of simultaneously producing and granulating composite materials for simultaneous internal delivery of high amounts of calcium and phosphate to a subject (person or animal)...
|
|
|
7273618 |
Method for administering agents to the central nervous system
The present invention is directed to a method for delivering agents to the central nervous system by way of a tissue innervated by the trigeminal nerve that is outside the nasal cavity. Such a...
|
|
|
7273604 |
Anti-asthmatic combinations comprising surface active phospholipids
Disclosed is a combination product for use in treating asthma and other respiratory conditions comprising a medicament comprising a surface active phospholipid composition in the form of a fine...
|
|
|
7273896 |
Compositions and methods of using a transient colorant
This invention relates generally to compositions and systems for forming biomaterials containing a transient colorant for visualizing tissue or surgical materials coated with such biomaterials, to...
|
|
|
7273624 |
Stable dosage forms containing ubiquinones
The invention relates to stable solid dosage forms for peroral administration containing, in addition to an ubiquinone, at least one thermoplastically processible matrix-forming auxiliary agent.
|
|
|
7270832 |
Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation
A suspension of biocompatible particles based on a double-block hydrophilic neutral polyminoacid/hydrophobic neutral polyaminoacid copolymer and suitable for carrying active principles. The carrier...
|